XML 26 R15.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Note 9 - Prepaid Forward Obligation | 9 Months Ended
--- | ---
Sep. 30, 2022
Notes to Financial Statements |
Prepaid Forward Obligation Disclosure [Text Block] | Note 9 – Prepaid Forward Obligation In March 2021, the Company entered into a prepaid forward agreement with RTW Investments (“RTW”). Under the terms of the RTW Transaction, the Company received $75.0 million ($72.4 million net of transaction costs) to support the continued launch of Jelmyto and the development of UGN-102. In return for the transferred funds, RTW is entitled to receive tiered, future cash payments based on aggregate worldwide annual net product sales of Jelmyto in an amount equal to: (i) 9.5% of annual net sales up to $200 million, (ii) 3.0% of annual net sales for annual net sales between $200 million and $300 million, and (iii) 1.0% of annual net sales for annual net sales above $300 million. If certain revenue thresholds for Jelmyto aggregate worldwide annual net sales are not met, the future cash payments to RTW with respect to Jelmyto annual net sales up to $200 million will increase by 3.5%, and may decrease back to 9.5% dependent on the Company meeting certain subsequent Jelmyto aggregate worldwide annual net sales thresholds. The rate in effect for the nine months ended September 30, 2022 for annual sales up to $200 million was 13.0%. In addition, subject to FDA approval of UGN-102, RTW is entitled to receive tiered, future cash payments based on aggregate worldwide annual net product sales of UGN-102 in an amount equal to: (i) 2.5% of annual net sales up to $200 million, (ii) 1.0% of annual net sales for annual net sales between $200 million and $300 million, and (iii) 0.5% of annual net sales for annual net sales above $300 million. If the Company does not receive FDA approval for UGN-102 by a specified date, the future cash payments to RTW with respect to aggregate worldwide annual net sales of Jelmyto across all Jelmyto annual net sales tiers will increase by 1.5%. In accordance with the prepaid forward agreement, the Company will be required to make payments of amounts owed to RTW each calendar quarter, through and until the quarter in which the aggregate cash payments received by RTW are equal to or greater than $300 million. As security for the payment and fulfilment of these amounts throughout the arrangement, the Company has granted RTW a first priority security interest in Jelmyto and UGN-102, including the regulatory approvals, intellectual property, material agreements, proceeds and accounts receivable related to these products. In May 2021, following the receipt of necessary regulatory approvals, the Company received the $75.0 million prepaid forward payment ($72.4 million net of transaction costs) from RTW and recognized an associated prepaid forward obligation liability. Each period the Company makes a payment to RTW, an expense is recognized related to financing on the prepaid forward obligation based on an imputed rate derived from the expected future payments. Management reassesses the effective rate each period based on the current carrying value of the obligation and the revised estimated future payments. Changes in future payments from previous estimates are included in future financing expense. The Company does not expect to make any principal payments in the next 12 months. The following table shows the activity with respect to the carrying value of the prepaid forward liability, in thousands:
Prepaid forward obligation at closing of RTW Transaction |  | $ | 75,000 |
Capitalized closing costs |  |  | (2,599 | )
Financing on prepaid forward obligation |  |  | 17,291 |
Amounts paid and payable |  |  | (3,979 | )
Carrying value of prepaid forward obligation as of December 31, 2021 |  |  | 85,713 |
Financing on prepaid forward obligation |  |  | 16,478 |
Amounts paid and payable |  |  | (5,999 | )
Carrying value of prepaid forward obligation as of September 30, 2022 |  | $ | 96,192 |

X
- Definition The entire disclosure for the prepaid forward obligation. + References No definition available. + Details
Name: | urgn_PrepaidForwardObligationDisclosureTextBlock
Namespace Prefix: | urgn_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration